Pharma-Bio Serv (PBSV) Dividend Yield (2019 - 2026)

Pharma-Bio Serv (PBSV) has reported Dividend Yield for 8 consecutive years, with 15.0% the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Dividend Yield fell 131.0% year-over-year to 15.0%; the trailing twelve-month figure through Jan 2026 stood at 0.02% (changed 0.0% YoY), and the FY2025 full-year result was 13.9%, up 97.0% from the prior year.
• Dividend Yield grew to 15.0% in Q2 2026 per PBSV's latest filing, from 12.71% in the prior quarter.
• Across five years, Dividend Yield topped out at 16.31% in Q2 2025 and bottomed at 12.71% in Q1 2026.
• Historically, Dividend Yield has averaged 5.26% across 5 years, with a median of 7.81% in 2024.
• The widest YoY moves for Dividend Yield: up 617 bps in 2025, down 2030 bps in 2025.
• Over 5 years, Dividend Yield stood at 8.16% in 2022, then fell by 10 bps to 7.36% in 2023, then soared by 38 bps to 10.14% in 2024, then jumped by 61 bps to 16.31% in 2025, then decreased by 8 bps to 15.0% in 2026.
• According to Business Quant data, Dividend Yield over the past three periods registered 15.0%, 12.71%, and 16.31% for Q2 2026, Q1 2026, and Q2 2025 respectively.